GNAS and neoplasm: The higher prevalence of NEJGNAS detection compared to NEJRPL22 may stem from the higher transcript expression level of GNAS in tumours, enhancing its immunogenicity and tumour-specific killing by TCRG4.1 (Fig. 5f,g).